[27]
The question to be decided by the court is whether the claims made in the applicants' patents are being infringed. The respondent Nu-Pharm submits that the applicants' process is similar to that of the respondents' and its drug supplier as set out in the NDS. Eventually with the assistance of expert chemists the court will look at the process of the drug supplier and compare the chemicals set out therein with the patented claims and determine if there is chemical equivalence or not.